Müller, D. C., Murtha, A. J., Bacon, J. V. W., Stephenson, M., Wells, C., Vasquez-Rios, C., Rostin, K., Rebane, L., Schönlau, E., Nikkola, J., Alimohamed, N., Basappa, N. S., Finch, D., Ko, J. J., Lavoie, J., Nappi, L., Noonan, K., Ong, M., Ozgun, G., Parimi, S., Soleimani, M., Sridhar, S. S., Toren, P., Winquist, E., Bernales, C. Q., Koudjanian, M., Atwal, J., Fung, E., Khan, L., Eigl, B., Othman, D., Bismar, T. A., Wang, G., Merza, R., Papadakis, A. I., Spatz, A., Kollmannsberger, C., Maurice-Dror, C., Annala, M., Chi, K. N., Vandekerkhove, G., Wyatt, A. W., Eigl, B. J. (2026). Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer. Nature Communications. https://doi.org/10.1038/s41467-026-69927-7